Key result
Diadenosine polyphosphates reduced coronary perfusion pressure and altered electrophysiologic variables in isolated guinea-pig hearts.
Diadenosine polyphosphates exert potent coronary vasomotor and cardiac electrophysiologic effects via purinergic receptors, suggesting a potential role during platelet activation in acute coronary syndromes.
Answers are grounded in this paper and cite their sources.
These effects in isolated guinea-pig hearts warrant caution before human translation; hypothesis-generating for coronary and electrophysiologic actions.
Platelet activation in heart disease is important owing to the effects of platelet-derived compounds on myocardial perfusion and cardiac electrophysiology. Diadenosine polyphosphates are secreted from platelets and present in the myocardium, but their electrophysiologic and vasomotor effects are incompletely understood. We used isolated guinea-pig hearts to study the effects of diadenosine triphosphate (Ap3A), tetraphosphate (Ap4A), pentaphosphate (Ap5A), and hexaphosphate (Ap6A) (10 pM-0.1 mM), comparing their actions to those of adenosine, adenosine triphosphate, and non-hydrolyzable Ap4A and Ap5A analogs. Diadenosine polyphosphates (0.1 nM-0.1 microM) transiently reduced coronary perfusion pressure, which recovered during the continued presence of the compounds. At concentrations greater than 0.1 microM effects were maximal and sustained (perfusion pressure decreased from 36.5+/-3.4 to 18.6+/-2.5 mm Hg, p < 0.001, with 1 microM Ap4A). The changes in action potential duration and refractory period developed slowly but were maintained (0.1 nM-1 microM). With 1 nM Ap4A, action potential duration increased from 170.6+/-2.6 to 187.3+/-3.8 ms, p < 0.05, and refractory period increased from 138.5+/-1.6 to 147.9+/-2.0 ms, p < 0.05. Ap4A and its analog reduced QRS duration (from 24.7+/-1.1 to 13.9+/-1.6 ms with 1 microM Ap4A, p < 0.05). P2-purinergic (adenosine triphosphate) receptor antagonism (suramin) reduced perfusion pressure but was without electrophysiologic effect. Other changes in coronary perfusion pressure and electrophysiologic variables associated with Ap4A were not seen in the presence of suramin. P1-(adenosine) antagonism (8-[p-sulfophenyl]theophylline) attenuated the electrophysiologic effects only. Diadenosine polyphosphates have potent cardiac electrophysiologic and coronary vasomotor effects via purinergic receptors, suggesting an important role during platelet activation in acute coronary syndromes.
No takes yet. Share an insight, caveat, or question.
Stavrou et al. (2001) studied Coronary vasomotor and cardiac electrophysiologic effects. Diadenosine polyphosphates (Ap3A, Ap4A, Ap5A, Ap6A) and nonhydrolyzable analogs vs. Adenosine, adenosine triphosphate, and baseline was evaluated on Coronary perfusion pressure (p=< 0.001). Diadenosine polyphosphates reduced coronary perfusion pressure and altered electrophysiologic variables in isolated guinea-pig hearts.
Synapse has enriched 10 related papers. Consider them for comparative context: